Accepted answer
Panels during active loss are worth drawing, and your instinct is right that several markers are systematically distorted. The distortions fall into three mechanisms: changes in muscle mass, changes in intake, and the mobilisation of fat itself. Knowing which mechanism affects which marker is what makes the panel interpretable.
Worth drawing, and interpretable during active loss
- Full blood count. Anaemia from reduced iron intake or malabsorption is common and easily missed. Also gives you mean cell volume, which points at iron versus B12 or folate.
- Ferritin, with CRP alongside. Ferritin rises with inflammation, so an isolated ferritin is uninterpretable without CRP. This is the most commonly mishandled pair on any panel.
- B12 and folate. Intake falls, and reduced gastric acid or altered gastric handling can affect B12 absorption.
- Sodium, potassium, magnesium, calcium, phosphate. Cheap, and the ones that change fastest with GI losses.
- Urea and creatinine. With the caveats below, and worth having a value from a period of stable intake.
- Thyroid function. Interpretable, with a caveat: energy restriction lowers T3 without changing TSH much, so a low-normal free T3 with a normal TSH during a deficit is usually adaptation rather than thyroid disease. Do not treat that.
- HbA1c. Interpretable and will usually improve markedly.
- Liver enzymes and bilirubin. Interpretable, and worth a baseline given both fatty liver improvement and gallbladder risk on rapid loss.
- Vitamin D. Falls with reduced intake, common regardless.
Distorted by active loss, interpret cautiously
| Marker | Direction of distortion | Mechanism | Consequence |
| Creatinine and creatinine-based eGFR | Creatinine falls, eGFR looks better | Less muscle generating creatinine, plus reduced meat intake | Falsely reassuring. Can conceal a real decline in filtration. Cystatin C is unaffected by muscle mass and is the better choice if the question matters |
| Triglycerides | Fall substantially | Genuine improvement plus fasting and reduced intake | Real improvement, but the magnitude is exaggerated during active loss and partly reverts at maintenance |
| LDL cholesterol | Can rise transiently during rapid loss | Mobilisation of cholesterol from adipose tissue | False alarm. A rise during rapid loss frequently resolves at weight stability. Do not start a statin on a single value drawn mid-loss without repeating it |
| Liver enzymes | Usually fall; occasionally rise transiently | Hepatic fat mobilisation | A modest transient rise during rapid loss is common; a large or progressive one is not and needs investigating |
| Uric acid | Can rise during rapid loss or fasting | Ketones compete with urate for renal excretion | Can precipitate gout in the susceptible. A rise mid-loss is not a chronic finding |
| Free T3 | Falls | Reduced peripheral conversion during energy restriction | Adaptation, not disease. A source of a great deal of unnecessary thyroid treatment |
| Albumin | Can fall modestly | Reduced intake, and it is also an acute-phase reactant | Rarely means protein malnutrition at these levels, but it drags calcium down with it, so use adjusted calcium |
| Ferritin | Can be normal despite iron deficiency | Inflammation raises it | Always pair with CRP. Transferrin saturation helps |
| Cortisol | Can rise modestly | Energy restriction is a stressor | Do not investigate a mildly raised cortisol during a large deficit without a reason |
Timing
Two principles, and they conflict, so you need both:
For a baseline you can compare against later, draw when stable. Ideally before starting, which is now impossible for you, or at a period of weight stability. Everything distorted above becomes interpretable at stability, so a maintenance-phase panel is the one that is worth keeping as a reference.
For catching a developing problem, draw during the risk period, which is exactly when the distortions are worst. Accept the distortions and interpret with them in mind.
A defensible schedule for someone in your position: one panel now while losing, one at three to six months after weight stabilises, then annually. Add a panel within days of any episode of vomiting or diarrhoea lasting more than a couple of days, or if any new symptom appears. And repeat rather than act on any single distorted value, particularly LDL.
Your specific situation is the reassuring end of the spectrum: 0.5 kg/week at thirteen months is a moderate rate, no GI losses, adequate intake. That is a routine-surveillance panel rather than an investigation. The one thing I would add to the list for you specifically, at 29 kg down, is a discussion about bone density, because rapid and substantial weight loss reduces bone mineral density and the panel will not show you that.
edited 3 Feb 2026 by Dr_Yusuf_Adeyemi — removed a claim I could not source
4The LDL-rising-during-rapid-loss point prevented me from starting a statin I did not need. Repeat at stability was the right call. – u100_marks 4 months ago 3Low free T3 during a deficit being adaptation rather than disease deserves to be much better known. – ruaidhri_o_shea 2 months ago 6Creatinine-based eGFR being falsely reassuring after major weight loss is the most consequential item in the table. – RP_C18 9 days ago add a comment